About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Sequencing Considerations in mCRPC
Sequencing Considerations in mCRPC
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
K
Second Line Therapy Options in mCRPC
By
Karam Al-Issa
151 views
April 26, 2022
0 Comments
Login to view comments.
Click here to Login
Sequencing Considerations in mCRPC
51
Dana-Farber Cancer Institute
Lecture Summary - CARD Trial: Safety and Efficacy of Cabazitaxel in …
Feat.
A. Choudhury
09:06
Dana-Farber Cancer Institute
CARD Trial: Safety and Efficacy of Cabazitaxel in mCRPC & Age Su…
Feat.
A. Choudhury
08:33
Penn Medicine Abramson Cancer Center
Challenging Genitourinary Tumors: What’s New in Prostate Cancer
Feat.
V. Narayan
22:50
Stanford Medicine
Genetics/Genomics in Prostate Cancer
Feat.
M. Cooperberg
23:27
Stanford Medicine
Stanford Medicine Historical Landscape of Testing: Blood-Based Diagn…
Feat.
J. Leppert
38:10
Nebraska Oncology Society
ASCO 2022 Updates on Molecular Based Imaging for Prostate Cancer: Re…
Feat.
T. Hope
21:43
ecancer
ASCO 2022 on the Latest Developments in mHSPC and mCRPC
Feat.
H. Payne,
K. Chi,
K. Miller,
L. Krabbe
44:50
Masonic Cancer Center, University of Minnesota
New Therapeutic Discoveries and Mechanisms for CRPC
Feat.
K. Kelly
14:33
Martin Allen-Auerbach
Prostate Cancer Imaging Updates: What, Why, and When
06:00
Elena Castro
Cabazitaxel Activity in Men With mCRPC With & Without DNA Damage…
10:02
Eleni Efstathiou
The Role of Biomarkers in mCRPC
13:49
Benjamin L. Maughan
Finding the Optimal Sequence for mCRPC
07:31
Karam Al-Issa
Second Line Therapy Options in mCRPC
06:12
Giulia Baciarello
Patient Preference Between Cabazitaxel and Docetaxel for 1L Chemothe…